^131I治疗丙基硫氧嘧啶致Graves病ANCA相关性血管炎二例
被引量:2
摘要
例1患者女,20岁,Graves病9年,复发1个月。患者9年前因Graves病服用丙基硫氧嘧啶(propylthiouracil,PTU)治疗,2年后好转停药,1年后复发,继续服用PTU,2年后因“反复眼红半年余,咯血2个月余”入院,诊断为“PTU相关.陛抗中性粒细胞胞质抗体(anti-neutrophil cytoplasmic anfibodies,ANCA)阳性小血管炎”。入院时体格检查:T37.1℃,神清,全身皮肤黏膜(-),结膜无充血,甲状腺Ⅱ度肿大,质软,
出处
《中华核医学杂志》
CAS
CSCD
北大核心
2011年第3期210-211,共2页
Chinese Journal of Nuclear Medicine
参考文献10
-
1Dolman KM,von dem Borne AEG Kr,Goldschmeding R,et al.Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy.Lancet,1993,342:651-652.
-
2Batchelor N,Holley A.A fatal case of propylthiouracil-induced ANCA-positive vasculitis.Med Gen Med,2006,8:10.
-
3Ohta K,Shimizu M,Yokoyama T,et al.Analysis of MPO-ANCA subtypes in a patient with propylthiouracil-induced vasculitis with multiple complications.Clin Nephrol,2007,68:315-321.
-
4周明宣,林玲,黄子扬,肖进益,陈小青.丙基硫氧嘧啶诱发抗中性粒细胞胞质抗体阳性小血管炎三例并文献复习[J].中华风湿病学杂志,2004,8(6):350-353. 被引量:8
-
5Gao Y,Zhao MH.Review article:drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.Nephrology,2009,14:33-41.
-
6Gao Y,Zhao MH,Guo XH,et al.The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism.Endocr Res,2004,30:205-213.
-
7Panamonta O,Sumethkul V,Radinahmed P,et al.Propylthiouracil associated antineutrophil cytoplasmic antibodies(ANCA) in patients with childhood onset Graves′ disease.J Pediatr Endocrinol Metab,2008,21:539-543.
-
8Cin MO,Gursoy A,Morris Y,et al.Prevalence and clinical significance of antineutrophil cytoplasmic antibody in Graves′ patients treated with propylthiouracil.Int J Clin Pract,2009,63:299-302.
-
9Pandey S,Kushwaha RS,Mehndiratta P,et al.Carbimazole induced ANCA positive vasculities.J Assoc Physicians India,2008,56:801-803.
-
10陈慧敏,张晓婷.丙基硫氧嘧啶治疗Graves病时抗中性粒细胞胞浆抗体阳性的临床研究[J].中国地方病防治,2007,22(4):314-315. 被引量:1
二级参考文献11
-
1Choi HK, Merkel PA, Walker AM, et al. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies.Arthritis Rheum, 2000, 43: 405-413.
-
2Hori Y, Arizono K, Hara S, et al. Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with thiamazole therapy. Nephron, 1996, 74: 734-735.
-
3Kitahara T, Hiromura K, Maezawa A, et al. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA): review of literature. Clin Nephrol, 1997,47: 336-340.
-
4Harper L, Cockwell P, Savage CO. Case of propylthiouracilinduced ANCA associated small vessel vasculitis. Nephrol Dial Transplant, 1998, 13: 455-458.
-
5Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of anti-neutrophil cytoplasmic antibody in some patients with Graves′ disease. Thyroid, 2000,10: 595-599.
-
6唐福林 见:蒋明 朱立平 林孝义 等主编.药物性狼疮[A].见:蒋明,朱立平,林孝义,等主编.风湿病学[C].北京:科学技术出版社,1996.1057-1058.
-
7Doiman KM,Gans ROB-Vervaat TJ,at al.Goldschmeding R 1993 Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy.lancet 342:651 - 652.
-
8Gunton JE,Stiel J,Caterson RJ,McElduff A.1999 Clinical case seminar:Anti -thyroid drugs and antineutrophil cytoplasmic antibody positive vasculitis.A case report and review of the literature J Clin Endocrin Melad 84:13 -16.
-
9Sera N,Ashizawa K,Ando T,at al.Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves'disease.Thyroid 2000; 10:595 - 599.
-
10徐旭东,赵明辉,章友康,郭晓惠,王海燕.丙基硫氧嘧啶导致的抗中性粒细胞胞质抗体阳性小血管炎及其靶抗原研究[J].中华内科杂志,2002,41(6):404-407. 被引量:54
共引文献7
-
1吕洪华,赵美芳.以肾损害为主的丙基硫氧嘧啶相关小血管炎3例诊疗体会[J].现代中西医结合杂志,2005,14(14):1880-1881. 被引量:1
-
2杨虎天,魏强华.重视药源性血管炎的诊断[J].诊断学理论与实践,2006,5(4):281-282.
-
3黄坚,陈江华,李夏玉.丙基硫氧嘧啶致抗中性粒细胞胞质抗体相关血管炎临床分析[J].浙江预防医学,2006,18(12):75-76.
-
4吴东,王玉,方卫纲.第207例甲状腺功能亢进-贫血-呼吸衰竭[J].中华医学杂志,2010,90(22):1577-1579. 被引量:1
-
5徐霞,姜静波.丙基硫氧嘧啶相关性血管炎的临床分析[J].现代实用医学,2011,23(10):1121-1123. 被引量:3
-
6林玲,邹和建.重视丙硫氧嘧啶严重不良反应的早期识别与干预研究[J].药物不良反应杂志,2015,17(2):81-83. 被引量:4
-
7林夏鸿,陈晓毓,吴晓鸿,黄银琼.聚焦丙硫氧嘧啶安全性--内分泌视角[J].药物不良反应杂志,2015,17(2):87-88. 被引量:1
同被引文献42
-
1Noh JY, Yasuda S, Sato S, et al. Clinical characteristics of my- eloperoxidase antineutrophil cytoplasmic antibody-associated vascu- lifts caused by antithyroid drugs [ J ]. J Clin Endocrinol Metab, 2009, 94(8) : 2806-2811.
-
2Gao Y, Zhao MH, Guo XH, et al. The prevalence and target anti- gens of antithyroid drugs induced antineutrophil cytoplasmic anti- bodies (ANCA) in Chinese patients with hyperthyroidism [ J ]. Endoer Res, 2004, 30(2) : 205-213.
-
3Panamonta O, Sumethkul V, Radinahmed P, et al. Propylthio- uracil associated antineutrophil cytoplasmic antibodies (ANCA) in patients with childhood onset Graves' disease [ J ]. J Pediatr Endocfinol Metab, 2008, 21(6): 539-543.
-
4Gao Y, Zhao MH. Review article: Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis [ J ]. Nephrology (Carlton), 2009, 14(1): 33-41.
-
5Chen YX, Zhang W, Chen XN, et al. Propyhhiouracil-induced antineutrophil cytoplasmic antibody (ANCA)-associated renal vas- culitis versus primary ANCA-associated renal vasculitis: a compar- ative study[J]. J Rheumatol, 2012, 39(3) : 558-563.
-
6Vanek C, Samuels Mtt. Central nervous system vasculitis caused by propylthiouracil therapy: a case report and literature review [J]. Thyroid, 2005, 15(1) : 80-84.
-
7Gao Y, Chen M, Ye H, et al. The target antigens of antineutro- phil cytoplasmic antibodies (ANCA) induced by propykhiouracil [J]. Int Immunopharmaeol, 2007, 7(1) : 55-60.
-
8Tu L, Tsai YC, Huang JL, et al. Occult pulmonary hemorrhage as a rare presentation of propylthiouracil-induced vasculitis [ J ]. Pediatrics, 2011, 127(1): e245-e249.
-
9Jiang X, Khursigara G, Rubin RL. Transformation of lupus-indu- cing drugs to cytotoxic products by activated neutrophils [ J ]. Sci- ence, 1994, 266(5156): 810-813.
-
10Servonnet A, Gareia-Hejl C, Banal F, et al. Propylthiouracil-in- duced multispecific antineutrophil cytoplasmic antibodies [ J ]. Rev Med Interne, 2010, 31 (10) : e9-el0.
-
1赵天仪,李益明.丙硫氧嘧啶诱发抗中性粒细胞胞质抗体相关性血管炎患者Graves病治疗策略[J].药物不良反应杂志,2015,17(2):99-100. 被引量:7
-
2赖亚新,单忠艳.抗甲状腺药物的不良反应[J].中华全科医师杂志,2008,7(3):151-153. 被引量:1
-
3王瑞英,常湛,李娟,王倩,张松筠.MCP-1在甲状腺功能减退症大鼠肾脏中的表达及与甲状腺功能的关系[J].河北医科大学学报,2010,31(9):1033-1037. 被引量:1
-
4陈永熙,陈楠.丙硫氧嘧啶诱发抗中性粒细胞胞质抗体相关性血管炎特点[J].药物不良反应杂志,2015,17(2):93-94. 被引量:1
-
5林玲,陈小青.聚焦丙硫氧嘧啶安全性--弥漫性肺泡出血[J].药物不良反应杂志,2015,17(2):90-93.
-
6吴朝明,顾雪疆,应斌宇.丙硫氧嘧啶致严重肝损害及粒细胞减少症1例[J].新医学,2005,36(3):129-129.
-
7任蕾,张会娟,秦贵军,王守俊,齐蕾,张雯雯.甲状腺危象、自身免疫性三系减少合并丙硫氧嘧啶致ANCA相关性血管炎一例[J].郑州大学学报(医学版),2014,49(6):900-902. 被引量:1
-
8连小兰,白耀,戴为信,郭芝生,李伟,卢琳.丙基硫氧嘧啶治疗甲状腺功能亢进症引起显著性肝损伤[J].中国医学科学院学报,2004,26(2):172-177. 被引量:13
-
9陈小青,林玲.聚焦丙硫氧嘧啶安全性--抗中性粒细胞胞质抗体相关性血管炎[J].药物不良反应杂志,2015,17(2):88-90. 被引量:3
-
10吴小艳.FDA警告丙硫氧嘧啶导致严重肝损害[J].药物不良反应杂志,2009,11(3):224-225. 被引量:5